Inhibition of IL-1R1/MyD88 signalling promotes mesenchymal stem cell-driven tissue regeneration

Nature Communications

Volumn 7, Issue , 2016, Pages

  Martino, Mikaël M ^a   Maruyama, Kenta ^a   Kuhn, Gisela A ^b   Satoh, Takashi ^a   Takeuchi, Osamu ^a,c   Müller, Ralph ^b   Akira, Shizuo ^a  

^a OSAKA UNIVERSITY   (Japan)

^b ETH ZURICH   (Switzerland)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE B; BETA CATENIN; CYTOKINE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; GSK3B PROTEIN, MOUSE; IL1B PROTEIN, MOUSE; IL1R1 PROTEIN, MOUSE; MYD88 PROTEIN, MOUSE; TOLL LIKE RECEPTOR;

BONE; DIFFERENTIATION; EXPERIMENTAL STUDY; GENETIC ANALYSIS; INHIBITION; INJURY; MEDICINE; PROTEIN; REGENERATION; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE INJURY; BONE REGENERATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; INHIBITION KINETICS; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; TISSUE REGENERATION; ANIMAL; CELL MOTION; CHONDROCYTE; DIAGNOSTIC IMAGING; GENETICS; IMMUNOLOGY; INJURIES; KNOCKOUT MOUSE; MACROPHAGE; MESENCHYMAL STROMA CELL; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; MONOCYTE; OSTEOBLAST; PHYSIOLOGY; REGENERATION; SKULL; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; BONE REGENERATION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CHONDROCYTES; CYTOKINES; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; INTERLEUKIN-1BETA; MACROPHAGES; MESENCHYMAL STROMAL CELLS; MICE; MICE, KNOCKOUT; MONOCYTES; MYELOID DIFFERENTIATION FACTOR 88; OSTEOBLASTS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, INTERLEUKIN-1 TYPE I; REGENERATION; SIGNAL TRANSDUCTION; SKULL; TOLL-LIKE RECEPTORS; WNT SIGNALING PATHWAY; X-RAY MICROTOMOGRAPHY;

EID: 84961615427     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11051     Document Type: Article

References (70)

1. Aurora, A. B. & Olson, E. N. Immune modulation of stem cells and regeneration. Cell Stem Cell 15, 14-25 (2014).
2. Forbes, S. J. & Rosenthal, N. Preparing the ground for tissue regeneration: from mechanism to therapy. Nat. Med. 20, 857-869 (2014).
3. Trofin, E. A., Monsarrat, P. & Kemoun, P. Cell therapy of periodontium: from animal to human? Front. Physiol. 4, 325 (2013).
4. Grayson, W. L. et al. Stromal cells and stem cells in clinical bone regeneration. Nat. Rev. Endocrinol. 11, 140-150 (2015).
5. Neovius, E. & Engstrand, T. Craniofacial reconstruction with bone and biomaterials: review over the last 11 years. J. Plast. Reconstr. Aesthet. Surg. 63, 1615-1623 (2010).
6. Martino, M. M., Briquez, P. S., Maruyama, K. & Hubbell, J. A. Extracellular matrix-inspired growth factor delivery systems for bone regeneration. Adv. Drug. Deliv. Rev. 94, 41-52 (2015).
7. Stevens, M. M. Biomaterials for bone tissue engineering. Mater. Today 11, 18-25 (2008).
8. Martino, M. M. et al. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science 343, 885-888 (2014).
9. Jones, E. & Yang, X. Mesenchymal stem cells and bone regeneration: current status. Injury 42, 562-568 (2011).
10. Piccinini, A. M. & Midwood, K. S. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010, 672395 (2010).
11. Chen, G. Y. & Nunez, G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826-837 (2010).
12. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384 (2010).
13. Oyama, J. et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109, 784-789 (2004).
14. Tsung, A. et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201, 1135-1143 (2005).
15. Wu, H. et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117, 2847-2859 (2007).
16. Tang, S. C. et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. USA 104, 13798-13803 (2007).
17. Bujak, M. et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am. J. Pathol. 173, 57-67 (2008).
18. Thomay, A. A. et al. Disruption of interleukin-1 signaling improves the quality of wound healing. Am. J. Pathol. 174, 2129-2136 (2009).
19. Hyakkoku, K. et al. Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171, 258-267 (2010).
20. Shichita, T. et al. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat. Med. 18, 911-917 (2012).
21. Mirza, R. E., Fang, M. M., Ennis, W. J. & Koh, T. J. Blocking interleukin-1beta induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes. Diabetes 62, 2579-2587 (2013).
22. Bhattacharyya, S. et al. FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling. Sci. Transl. Med. 6, 232ra50 (2014).
23. Takemura, N. et al. Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome. Nat. Commun. 5, 3492 (2014).
24. Gomes, P. S. & Fernandes, M. H. Rodent models in bone-related research: the relevance of calvarial defects in the assessment of bone regeneration strategies. Lab. Anim. 45, 14-24 (2011).
25. Spicer, P. P. et al. Evaluation of bone regeneration using the rat critical size calvarial defect. Nat. Protoc. 7, 1918-1929 (2012).
26. Sims, J. E. & Smith, D. E. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10, 89-102 (2010).
27. Eggenhofer, E. et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front. Immunol. 3, 297 (2012).
28. Fischer, U. M. et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 18, 683-692 (2009).
29. Schindeler, A., McDonald, M. M., Bokko, P. & Little, D. G. Bone remodeling during fracture repair: the cellular picture. Semin. Cell Dev. Biol. 19, 459-466 (2008).
30. Bianco, P. et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 19, 35-42 (2013).
31. Zhou, B. O., Yue, R., Murphy, M. M., Peyer, J. G. & Morrison, S. J. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 15, 154-168 (2014).
32. Chan, C. K. et al. Identification and specification of the mouse skeletal stem cell. Cell 160, 285-298 (2015).
33. Worthley, D. L. et al. Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. Cell 160, 269-284 (2015).
34. van Rooijen, N. & Hendrikx, E. Liposomes for specific depletion of macrophages from organs and tissues. Methods Mol. Biol. 605, 189-203 (2010).
35. Caplan, A. I. & Correa, D. PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. J. Orthop. Res. 29, 1795-1803 (2011).
36. Long, F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell. Biol. 13, 27-38 (2012).
37. Baron, R. & Kneissel, M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 19, 179-192 (2013).
38. Manning, B. D. & Cantley, L. C. AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274 (2007).
39. Huang, S. M. et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461, 614-620 (2009).
40. Quiniou, C. et al. Development of a novel noncompetitive antagonist of IL-1 receptor. J. Immunol. 180, 6977-6987 (2008).
41. Schense, J. C. & Hubbell, J. A. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjug. Chem. 10, 75-81 (1999).
42. Martino, M. M., Briquez, P. S., Ranga, A., Lutolf, M. P. & Hubbell, J. A. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc. Natl Acad. Sci. USA 110, 4563-4568 (2013).
43. Derossi, D., Joliot, A. H., Chassaing, G. & Prochiantz, A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269, 10444-10450 (1994).
44. Hollinger, J. O. & Kleinschmidt, J. C. The critical size defect as an experimental model to test bone repair materials. J. Craniofac. Surg. 1, 60-68 (1990).
45. Liu, Y. et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha. Nat. Med. 17, 1594-1601 (2011).
46. Burzyn, D. et al. A special population of regulatory T cells potentiates muscle repair. Cell 155, 1282-1295 (2013).
47. Arslan, F. et al. Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction. Circ. Res. 108, 582-592 (2011).
48. Pinho, S. et al. PDGFRalpha and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. J. Exp. Med. 210, 1351-1367 (2013).
49. Fernandez-Moure, J. S. et al. Enhanced osteogenic potential of mesenchymal stem cells from cortical bone: a comparative analysis. Stem Cell Res. Ther. 6, 203 (2015).
50. Lv, F. J., Tuan, R. S., Cheung, K. M. & Leung, V. Y. Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells 32, 1408-1419 (2014).
51. Chang, J. et al. NF-kappaB inhibits osteogenic differentiation of mesenchymal stem cells by promoting beta-catenin degradation. Proc. Natl Acad. Sci. USA 110, 9469-9474 (2013).
52. Chen, J., Crawford, R., Chen, C. & Xiao, Y. The key regulatory roles of the PI3K/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration. Tissue. Eng. Part B Rev. 19, 516-528 (2013).
53. Whyte, J. L., Smith, A. A. & Helms, J. A. Wnt signaling and injury repair. Cold Spring Harb. Perspect. Biol. 4, a008078 (2012).
54. Muschler, G. F., Raut, V. P., Patterson, T. E., Wenke, J. C. & Hollinger, J. O. The design and use of animal models for translational research in bone tissue engineering and regenerative medicine. Tissue Eng. Part B Rev. 16, 123-145 (2010).
55. Reichert, J. C. et al. A tissue engineering solution for segmental defect regeneration in load-bearing long bones. Sci. Transl. Med. 4, 141ra93 (2012).
56. Gao, X. et al. A comparison of bone regeneration with human mesenchymal stem cells and muscle-derived stem cells and the critical role of BMP. Biomaterials 35, 6859-6870 (2014).
57. Ratcliffe, E., Glen, K. E., Naing, M. W. & Williams, D. J. Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies. Br. Med. Bull. 108, 73-94 (2013).
58. Steinert, A. F., Rackwitz, L., Gilbert, F., Noth, U. & Tuan, R. S. Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives. Stem Cells Transl. Med. 1, 237-247 (2012).
59. Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122 (1999).
60. Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643 (2003).
61. Takeuchi, O. et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169, 10-14 (2002).
62. Uematsu, S. et al. Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells. Nat. Immunol. 7, 868-874 (2006).
63. Hemmi, H. et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3, 196-200 (2002).
64. Hoshino, K. et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749-3752 (1999).
65. Takeuchi, O. et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11, 443-451 (1999).
66. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
67. Hildebrand, T., Laib, A., Muller, R., Dequeker, J. & Ruegsegger, P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J. Bone Miner. Res. 14, 1167-1174 (1999).
68. Lutolf, M. P. et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat. Biotechnol. 21, 513-518 (2003).
69. Maruyama, K. et al. Strawberry notch homologue 2 regulates osteoclast fusion by enhancing the expression of DC-STAMP. J. Exp. Med. 210, 1947-1960 (2013).
70. Martino, M. M. et al. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci. Transl. Med. 3, 100ra89 (2011).